NCPA's qAM

qAM

Changes on the way for track-and-trace

by NCPA | May 29, 2019

Requirements for wholesalers that may have consequences for your pharmacy under the Drug Supply Chain Security Act (also known as the "track-and-trace law") are coming. After Nov. 27, 2019, wholesalers can only accept pharmaceutical products from any trading partner, including pharmacies, that have a DSCSA-compliant product identifier, unless subject to a waiver, exception, or exemption under the law or it meets FDA guidance regarding grandfathered product. Furthermore, after this date, wholesalers will be required to verify with the manufacturer the DSCSA-compliant product identifier before redistributing a saleable return. It is important for community pharmacists to know this date because the change may affect saleable returns and inventory management at the pharmacy level. NCPA recommends that pharmacy owners immediately ask their trading partners how these compliance dates may affect your pharmacy and plan accordingly. Here are requirements and more information from the FDA.